The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study
| Image |  |
|---|---|
| Description | scientific article published on 8 November 2013 |
| Author/s |
author: Timothy Price John Zalcberg Deborah Schofield Hannah Carter |
| Publication date | November 8, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |